Singapore, Nov. 6 -- Molnlycke(R) Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the commencement of its new wound care manufacturing site in Changshu, China. This strategic investment marks a milestone in Molnlycke's growth journey and the beginning of localised manufacturing in one of the world's fastest-growing MedTech markets.

The site in Changshu marks another step forward in Molnlycke's ambition to manufacture products closer to where they are sold. It reflects the company'sglocal approach, combining global standards with local relevance, and reinforces our commitment to sustainable growth, supply chain resilience and faster delivery of life-changing wound care solutions to caregivers a...